- Topic
51k Popularity
28k Popularity
16k Popularity
32k Popularity
18k Popularity
7k Popularity
143k Popularity
69k Popularity
1791k Popularity
- Pin
- 🎉 Gate US Stock Token Trading is Now Live! Spot, Futures, and Alpha Zone – All Open!
📝 Share your trading experience or screenshots on Gate Square to unlock $1,000 rewards!
🎁 5 top Square creators * $100 Futures Voucher
🎉 Share your post on X – Top 10 posts by views * extra $50
How to Participate:
1️⃣ Follow @Gate_Square
2️⃣ Make an original post (at least 20 words) with #Gate US Stock Trading Share#
3️⃣ If you share on Twitter, submit post link here: https://www.gate.com/questionnaire/6854
Note: You may submit the form multiple times. More posts, higher chances to win!
📅 July 3, 7:00
- 🎉 Congratulations to the following users for winning in the #Gate CBO Kevin Lee# - 6/26 event!
KaRaDeNiZ, Sakura_3434, Anza01, asiftahsin, GateUser-d0654db3, milaluxury, Ryakpanda, 静.和, milaluxury, 币大亨1
💰 Each winner will receive $5 Points!
🎁 Rewards will be distributed within 14 working days. Please make sure to complete identity verification to be eligible.
📌 Event details: https://www.gate.com/post/status/11782130
🙏 Thank you all for your enthusiastic participation — more exciting events are on the way!
- 🔥Post & Earn Passive Income! Gate Square’s "Content Mining" Channel is Now Open!🔥
Every post has a chance to earn up to 10% rebate from user trading fees.
Text, images, or videos—earn while you share!
Sign up now 👇Turn your social influence into real cash!
https://www.gate.com/announcements/article/45695
- #Gate Ranks Top 4 Exchange#
Gate has reached the Top 4 global crypto derivatives exchanges on CoinMarketCap, with a 24-hour trading volume exceeding $15 billion. Enjoy some of the lowest fees in the industry—maker fees as low as 0.015%. Gate is committed to providing users with a more efficient and cost-effective trading experience, making it your top choice for crypto trading!
Start trading now:
👉 Spot Trading: https://www.gate.com/trade
👉 Alpha Trading: https://www.gate.com/alpha
👉 Futures Trading: https://www.gate.com/futures
💬 What derivatives or other products have you recently traded
Innovent Biologics: Positive Results from Phase II Clinical Trial of Innovative Drug ICP-488
Jinshi data news on October 9th, Norcheng Jianhua announced in the evening that the company's innovative drug ICP-488 achieved positive clinical trial results in a phase II randomized, double-blind, placebo-controlled study in patients with moderate to severe plaque psoriasis. The results showed that patients treated with 6mg and 9mg (once daily) of ICP-488 had significant improvement in PASI75 at week 12 compared to patients receiving placebo. In addition, the proportion of patients receiving ICP-488 treatment who achieved PASI90, PASI100, and static Physician Global Assessment (sPGA) 0/1 (i.e., complete or near-complete clearance of skin lesions) was significantly higher than that in the placebo group.